Markets.com Logo
markets.com

4BL

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

The financial product symbol 4BL.F refers to the stock of Carl Zeiss Meditec AG traded on the Frankfurt Stock Exchange (FSE). Carl Zeiss Meditec AG is a German medical technology company that develops and distributes ophthalmic and microsurgical products. The ".F" extension designates that the stock is being traded on the Frankfurt Stock Exchange. Investors interested in purchasing shares of Carl Zeiss Meditec AG can do so through brokers that provide access to the Frankfurt Stock Exchange, using the ticker symbol 4BL.F to identify the specific security. It's important to consult with a financial advisor and conduct thorough research before making any investment decisions.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Company Performance: Revenue, earnings, and profit margins of 4BL.F influence investor sentiment.

Industry Trends: The performance of the broader biotechnology sector impacts 4BL.F's stock price.

Regulatory Environment: Changes in regulations affecting pharmaceutical approvals can shift investor confidence.

Market Sentiment: Overall investor confidence and risk appetite influence the demand for 4BL.F shares.

Economic Conditions: Economic growth or recessionary pressures impact investment decisions and stock valuations.

Competition: The competitive landscape within the biotechnology industry affects market share and future prospects.

News & Announcements: Significant news related to 4BL.F, such as clinical trial results, can cause price volatility.

Global Events: Major global events can have a broad impact on financial markets, affecting 4BL.F's stock price.

People Also Watch

Markets

    Latest news

    Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

    Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

    Julian Parker|--
    McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

    McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

    Julian Parker|--
    Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

    Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

    Julian Parker|--

    Latest Education Articles

    Risk Management 101

    Risk Management 101

    Julian Parker|--
    Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

    Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

    Julian Parker|--
    Gold Scalping Strategy: How Scalping XAU/USD Works

    Gold Scalping Strategy: How Scalping XAU/USD Works

    Julian Parker|--
    Recommended Topics
    markets.com